<DOC>
	<DOC>NCT02356276</DOC>
	<brief_summary>The purpose of this study is to study the efficacy of hyperthermic intraperitoneal chemotherapy in the treatment of patients with locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy. It is a multicentric and randomised phase III trial.</brief_summary>
	<brief_title>Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>18 &lt; age ≤ 70 years old Male or Non pregnant female The Eastern Cooperative Oncology Group (ECOG) status 01 T3 or T4 gastric adenocarcinoma (visual determination according to AJCC 2010 7th edition) No distance metastasis, eligible for D2 lymphadenectomy Have not received cytotoxic chemotherapy, radiotherapy or immunotherapy White blood cells &gt; 4,000/mm3 neutrophils ≥ 1,500/mm3 platelets ≥ 100,000/mm3 hemoglobin&gt;9g/l Alanine transaminase (ALT) and aspartate aminotransferase (AST) &lt; or = 2.5 times upper limit of nominal (ULN) total bilirubin (TBIL) &lt; 1.5 times ULN serum creatinine &lt; 1 times ULN Having given written informed consent prior to any procedure related to the study Have other cancer within 5 years Existence of distance metastasis during surgey (M1) Prior malignant tumors with detectable signs of recurrence or distant metastasis Poorly controlled disease e.g. atrial fibrillation, stenocardia, cardiac insufficiency, persistent hypertension despite medicinal treatment, ejection fraction&lt;50% Epileptic seizures patients need medicine control Uncontroled mental disease or mental disorder Drug abuse or psychological or social factors affect the judgment of results Contraindication to any therapy contained in this regimen specific to the study Receiving other chemotherapy, radiotherapy or immunotherapy Without given written informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>